A retrospective study to assess the effect of dimethyl fumarate on lymphocyte count in patients with multiple sclerosis.
Phase of Trial: Phase IV
Latest Information Update: 19 Nov 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 19 Nov 2016 New trial record